Discovery & Translational Research
Whether you’re engineering cells to produce proteins and antibodies, fuel cell-based assays, drive vaccine development or deliver the next generation of cell or gene therapies, making workflows nimble and efficient is a critical step towards your ultimate destination.
Partner with a team of specialists who have spent over 20 years advancing electroporation. We offer technology and expertise that can accelerate your cell engineering journey and set you on a course for success.
Reliable electroporation to streamline your research
When you’re working with cells, variability is always a challenge that can cause delays. The time and effort spent determining if the problem is with the process or inherent to the biology of the system can distract from the scientific innovations that are your passion.
At MaxCyte® we’ve worked hard to remove the uncertainty from experimental protocols. We’ve spent years optimizing electroporation technology to ensure you can consistently deliver diverse payloads to a variety of cells.
Advance quickly and confidently with our ExPERT™ platform
MaxCyte’s technology offers a number of unique advantages including:
- Highly efficient delivery of diverse payloads, including
- Nucleic acids
- Proteins
- Small molecules
- Delivery to a variety of cell types
- High cell viability after electroporation
- Seamless scalability with the same technology and protocols from concept to commercialization
- Streamlined workflows with MaxCyte’s Electroporation Buffer
- Comprehensive technical support from our team of cell engineering experts
CRISPR electroporation using MaxCyte reduced keratinocyte transfection timelines by 4 weeks
This content was reproduced with kind permission from Aaron Tward’s Lab.
Build a strong foundation for future development
Whether you’re starting early discovery or about to scale your process, MaxCyte offers the best technology and support to streamline your research journey.
We’re empowering leading academic and early discovery labs with our best-in-class ExPERT instruments.
Join a growing list of researchers publishing studies enabled by MaxCyte
MaxCyte has been cited in hundreds of peer-reviewed papers and, together with our partners, has 35+ clinical trials from INDs referencing our US FDA master file.
Resources
Ready to learn more about how we can advance your discovery and translational research?
Answers are just a click away!
